Latest filing published 19 Dec 2024 for enVVeno Medical Corp, €30k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 43 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -86.9%Entry US$87.15 · Close at T+365 US$11.37
- -22.6%Entry US$129.85 · Close at T+365 US$100.45
- -21.3%Entry US$259.70 · Close at T+365 US$204.40
- -21.1%Entry US$259.00 · Close at T+365 US$204.40
- -28.6%Entry US$204.05 · Close at T+365 US$145.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert Andrew Berman: trading record in brief
This profile gathers the share dealings of Robert Andrew Berman across 3 companies, led by Anixa Biosciences Inc, Acacia Research Corp and enVVeno Medical Corp. Over a trading history stretching from 26 April 2006 to 19 December 2024, the count stands at 64 filings.
In open-market terms, that means 44 purchases worth €248k on one side and 8 sales worth €1.1M on the other. On balance, insiders were net sellers of €813k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 2 share grants and 8 option exercises. 2024 to date brings 1 purchase and no sales.
The median purchase comes to €3,391. 3 out of 9 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 43 purchases show a median change of -15.0%, with the price up in 40% of them. This is a record of the past, not a forecast.
The newest entry dates from 19 December 2024: an open-market purchase of €30k, in enVVeno Medical Corp. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Robert Andrew Berman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,000 shares@ US$2.5545.2% of flowCommon StockSEC:0001493152-24-050865:0Canonical exit: 19 Mar 2025 (T+90)
- 2,500 shares@ US$3.800.14% mcap13.7% of flowCommon StockSEC:0001493152-22-017957:0Canonical exit: 25 Sept 2022 (T+90)
- 200,000 sharesCommon StockSEC:0001493152-21-030335:0
- 2,000 shares@ US$7.4320.0% of flowCommon StockSEC:0001493152-21-029430:0Canonical exit: 17 Feb 2022 (T+90)
- 2,000 shares@ US$7.8721.2% of flowCommon StockSEC:0001493152-21-029229:0Canonical exit: 14 Feb 2022 (T+90)
- 3,000 shares@ US$5.47100.0% of flowCommon Stock, $0.00001 par valueSEC:0001493152-21-012298:0Canonical exit: 16 Aug 2021 (T+90)
- 18,382 shares@ US$1.3618.0% of flowCommon StockSEC:0001493152-19-005579:0Canonical exit: 10 Jun 2019 (T+90)
- 21,740 shares@ US$1.1518.0% of flowCommon StockSEC:0001493152-19-003384:0Canonical exit: 10 Jun 2019 (T+90)
- 100 shares@ US$0.850.4% of flowCommon StockSEC:0001513162-17-000183:0Canonical exit: 31 Aug 2017 (T+90)
- 9,900 shares@ US$0.8836.6% of flowCommon StockSEC:0001513162-17-000183:1Canonical exit: 31 Aug 2017 (T+90)
- 5,995 shares@ US$2.3863.0% of flowCommon StockSEC:0001513162-17-000104:0
- 5,000 shares@ US$5.77Common StockSEC:0001513162-15-000424:0Canonical exit: 19 Oct 2015 (T+90)
- 200 shares@ US$4.00Common StockSEC:0001513162-15-000397:0Canonical exit: 8 Oct 2015 (T+90)
- 200 shares@ US$3.80Common StockSEC:0001513162-15-000389:0Canonical exit: 5 Oct 2015 (T+90)
- 600 shares@ US$3.75Common StockSEC:0001513162-15-000384:0Canonical exit: 28 Sept 2015 (T+90)
- 500 shares@ US$3.95Common StockSEC:0001513162-15-000384:1Canonical exit: 29 Sept 2015 (T+90)
- 312 shares@ US$5.00Common StockSEC:0001513162-15-000379:0Canonical exit: 24 Sept 2015 (T+90)
- 1,400 shares@ US$4.07Common StockSEC:0001513162-15-000379:1Canonical exit: 27 Sept 2015 (T+90)
- 20,000 shares@ US$0.14Common StockSEC:0001513162-15-000364:0Canonical exit: 17 Sept 2015 (T+90)
- 60,000 shares@ US$0.1504Common StockSEC:0001513162-15-000364:1Canonical exit: 20 Sept 2015 (T+90)
- 30,000 shares@ US$0.136Common StockSEC:0001513162-15-000351:0Canonical exit: 13 Sept 2015 (T+90)
- 50,000 shares@ US$0.1349Common StockSEC:0001513162-15-000351:1Canonical exit: 15 Sept 2015 (T+90)
- 50,000 shares@ US$0.1297Common StockSEC:0001513162-15-000351:2Canonical exit: 16 Sept 2015 (T+90)
- 25,000 shares@ US$0.1423Common StockSEC:0001513162-15-000334:0Canonical exit: 9 Sept 2015 (T+90)
- 10,000 shares@ US$0.1399Common StockSEC:0001513162-15-000329:0Canonical exit: 7 Sept 2015 (T+90)
25 of 62 declarations
